Salvage therapy options for myeloma patients.
Hussein
Mohamad A
MA
Cleveland Clinic Multiple Myeloma Program Cleveland, Ohio, USA.
D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003131:Combined Modality Therapy; D003907:Dexamethasone / Q000627:therapeutic use; D004317:Doxorubicin / Q000008:administration & dosage; D005047:Etoposide / Q000008:administration & dosage; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008297:Male; D009101:Multiple Myeloma / Q000628:therapy*; D010956:Plasmapheresis; D018714:Radiotherapy, Adjuvant; D016879:Salvage Therapy; D013131:Spine / Q000473:pathology / Q000601:surgery; D013792:Thalidomide / Q000627:therapeutic use
D005938:Glucocorticoids; D007166:Immunosuppressive Agents; D013792:Thalidomide; D005047:Etoposide; D003907:Dexamethasone; D004317:Doxorubicin